Biphasic Insulins [clinicaltrials_resource:c9c059240616e06d8a6f20195ac62061]
clinicaltrials:NCT00082407Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes [clinicaltrials:NCT00097279]Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes [clinicaltrials:NCT00097877]INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study [clinicaltrials:NCT00101751]Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 Diabetes [clinicaltrials:NCT00184561]Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes [clinicaltrials:NCT00184574]clinicaltrials:NCT00184600Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes. [clinicaltrials:NCT00184626]Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes [clinicaltrials:NCT00280046]Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 Diabetes [clinicaltrials:NCT00282451]A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70. [clinicaltrials:NCT00283218]Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea. [clinicaltrials:NCT00313001]Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 Diabetes [clinicaltrials:NCT00318786]clinicaltrials:NCT00384085clinicaltrials:NCT00393705clinicaltrials:NCT00469092Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus. [clinicaltrials:NCT00476437]clinicaltrials:NCT00537277Comparison of Biphasic Insulin Aspart Produced by the NN2000 Process to Current Process to in Type 2 Diabetes [clinicaltrials:NCT00564668]Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes [clinicaltrials:NCT00592969]Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy [clinicaltrials:NCT00598793]Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes [clinicaltrials:NCT00600366]Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes [clinicaltrials:NCT00600626]Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes [clinicaltrials:NCT00605020]Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes [clinicaltrials:NCT00605111]Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 Diabetes [clinicaltrials:NCT00612599]Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes [clinicaltrials:NCT00613951]Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes [clinicaltrials:NCT00617565]Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes [clinicaltrials:NCT00619697]Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes [clinicaltrials:NCT00624364]clinicaltrials:NCT00627445Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins [clinicaltrials:NCT00657319]Observational Study of Safety and Effectiveness of NovoMix® 30 for the Treatment of Diabetes [clinicaltrials:NCT00659282]Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes [clinicaltrials:NCT00665093]clinicaltrials:NCT00669864Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin [clinicaltrials:NCT00670722]Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes [clinicaltrials:NCT00671008]Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30 [clinicaltrials:NCT00675493]Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin [clinicaltrials:NCT00676741]Observational Study to Assess the Quality of Life and Clinical Outcomes in Subjects Using NovoMix® 30 for the Treatment of Diabetes [clinicaltrials:NCT00696163]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Biphasic Insulins [clinicaltrials_resource:c9c059240616e06d8a6f20195ac62061]
Bio2RDF identifier
c9c059240616e06d8a6f20195ac62061
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:c9c059240616e06d8a6f20195ac62061
identifier
clinicaltrials_resource:c9c059240616e06d8a6f20195ac62061
title
Biphasic Insulins
@en
type
label
Biphasic Insulins [clinicaltrials_resource:c9c059240616e06d8a6f20195ac62061]
@en